Cascadian Therapeutics, Inc. (CASC) has 35 open-market insider trades by 12 insiders since 2010. The most active filer is Robert C. Warren Jr., President & 10%.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Robert C. Warren Jr. | Pres10% | — | 11 | $5.7M | 2013-03-28 |
| Wendy W. Warren | 10% | — | 1 | $3.7M | 2012-12-27 |
| Michael E. Kern | VP-Construction Attach. Div. | — | 3 | $509K | 2011-01-04 |
| Scott Dunseth Myers | CEOPres | — | 8 | $326K | 2018-03-09 |
| Henry W. Wessinger II | Dir | — | 1 | $289K | 2013-03-28 |
| Christopher S. Henney | Dir | — | 1 | $208K | 2018-03-09 |
| Nancy Wilgenbusch | Dir | — | 2 | $177K | 2013-03-28 |
| Davide Roncari | PresVP | — | 1 | $160K | 2013-03-28 |
| James S. Osterman | Dir | — | 2 | $142K | 2013-03-28 |
| Ted W. Love | Dir | — | 1 | $98K | 2018-03-09 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Scott Dunseth Myers | President | Buy | $21K | 2017-08-11 |
| Scott Dunseth Myers | President | Buy | $11K | 2017-05-12 |
| Scott Dunseth Myers | President | Buy | $8K | 2017-03-31 |
| Gwen A. Fyfe | Director | Buy | $7K | 2017-03-28 |
| Scott Dunseth Myers | President | Buy | $4K | 2017-03-20 |
| Ted W. Love | Director | Buy | $98K | 2017-02-02 |
Companies that share insiders with CASC, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Christopher S. Henney | Director | Buy | $208K | 2017-01-30 |
| Scott Dunseth Myers | CEO & President | Buy | $77K | 2017-01-27 |
| Scott Dunseth Myers | CEO & President | Buy | $52K | 2016-08-17 |
| Scott Dunseth Myers | President | Buy | $103K | 2016-08-17 |
| Scott Dunseth Myers | CEO & President | Buy | $50K | 2016-06-28 |
| Wendy W. Warren | 10% | Sell | $3.7M | 2012-12-24 |
| James S. Osterman | Director | Sell | $70K | 2012-07-12 |
| James S. Osterman | Director | Sell | $72K | 2012-07-11 |
| Nicholas R. Lardy | Director | Sell | $21K | 2012-04-30 |